ARMISTICE CAPITAL, LLC Insider Trading Activity
Every SEC Form 4 transaction reported by ARMISTICE CAPITAL, LLC, sourced directly from SEC EDGAR and updated as new filings are accepted.
Quick Answer
Is ARMISTICE CAPITAL, LLC buying or selling?
ARMISTICE CAPITAL, LLC reported 151 open-market buys ($112.7M) and 29 sells ($398.7M) across 180 Form 4 filings at 19 companies — a net selling position of $285.9M.
Source: SEC EDGAR Form 4
Key Statistics (as of Jun 28, 2023)
Insider sentiment
Net sellingNet insider flow of $285.9M in net selling, filed between Jan 26, 2018 – Jun 28, 2023.
Companies ARMISTICE CAPITAL, LLC files for
| # | Company | Form 4 filings |
|---|---|---|
| 1 | AVTXCerecor Inc. | 58 |
| 2 | RSLSReShape Lifesciences Inc. | 22 |
| 3 | DFRGDel Frisco's Restaurant Group, Inc. | 21 |
| 4 | KPRXEYEGATE PHARMACEUTICALS INC | 16 |
| 5 | VXRTVaxart, Inc. | 13 |
| 6 | VLRXValeritas Holdings Inc. | 11 |
| 7 | CTDHCyclo Therapeutics, Inc. | 7 |
| 8 | VICLVICAL INC | 7 |
| 9 | AMAGAMAG PHARMACEUTICALS, INC. | 6 |
| 10 | TENXTENAX THERAPEUTICS, INC. | 5 |
Recent ARMISTICE CAPITAL, LLC transactions
| Date | Ticker | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| Jun 28, 2023 | AVTX | 10% Owner | Sale | 3.7M | $2.2M |
| Feb 9, 2023 | AVTX | 10% Owner | Purchase | 450.0K | $0 |
| Mar 14, 2022 | AVTX | Director, 10% Owner | Purchase | 226.0K | $151.9K |
| Feb 28, 2022 | AVTX | Director, 10% Owner | Purchase | 140.0K | $111.8K |
| Feb 22, 2022 | AVTX | Director, 10% Owner | Purchase | 288.0K | $231.6K |
| Jan 20, 2022 | AVTX | Director, 10% Owner | Purchase | 312.0K | $274.5K |
| Jan 14, 2022 | AVTX | Director, 10% Owner | Purchase | 455.0K | $452.8K |
| Jan 11, 2022 | AVTX | Director, 10% Owner | Purchase | 645.0K | $642.9K |
| Sep 17, 2021 | AVTX | Director, 10% Owner | Purchase | 5.7M | $12.6M |
| Aug 18, 2021 | AVTX | Director, 10% Owner | Purchase | 50.0K | $138.2K |
| Aug 6, 2021 | AVTX | Director, 10% Owner | Purchase | 150.0K | $408.5K |
| Aug 3, 2021 | KPRX | 10% Owner | Sale | 261.0K | $646.6K |
| Jul 29, 2021 | KPRX | Director, 10% Owner | Sale | 3.2M | $14.5M |
| Jun 22, 2021 | HIND | 10% Owner | Sale | 2.3M | $14.2M |
| May 18, 2021 | AVTX | Director, 10% Owner | Purchase | 180.0K | $392.5K |
| Jan 12, 2021 | AVTX | Director, 10% Owner | Purchase | 2.5M | $6.5M |
| Jan 9, 2021 | KPRX | Director, 10% Owner | Purchase | 1.5M | $8.0M |
| Dec 16, 2020 | AYTU | Director | Purchase | 1.3M | $8.0M |
| Dec 7, 2020 | AVTX | Director, 10% Owner | Purchase | 20.0K | $48.8K |
| Dec 4, 2020 | RSLS | 10% Owner | Purchase | 6.4K | $26.6K |
| Nov 25, 2020 | AVTX | 10% Owner | Purchase | 100.0K | $236.9K |
| Nov 18, 2020 | RSLS | 10% Owner | Purchase | 977 | $4.1K |
| Nov 12, 2020 | RSLS | 10% Owner | Purchase | 2.4K | $8.6K |
| Nov 5, 2020 | RSLS | 10% Owner | Purchase | 3.1K | $11.0K |
| Oct 1, 2020 | CTDH | 10% Owner | Sale | 10.5K | $1.4K |
Showing the 25 most recent filings of 180. Screen every filing.
ARMISTICE CAPITAL, LLC insider trading FAQ
Is ARMISTICE CAPITAL, LLC buying or selling?
Across 180 SEC Form 4 filings, ARMISTICE CAPITAL, LLC reported 151 open-market purchases totaling $112.7M and 29 sales totaling $398.7M — a net selling position of $285.9M.
Which companies does ARMISTICE CAPITAL, LLC file Form 4s for?
ARMISTICE CAPITAL, LLC has reported insider transactions at 19 companies, most often Cerecor Inc. (AVTX), ReShape Lifesciences Inc. (RSLS), Del Frisco's Restaurant Group, Inc. (DFRG), EYEGATE PHARMACEUTICALS INC (KPRX), Vaxart, Inc. (VXRT).
How far back does ARMISTICE CAPITAL, LLC's filing history go?
Trabud holds ARMISTICE CAPITAL, LLC's SEC Form 4 filings from Jan 26, 2018 – Jun 28, 2023, sourced directly from SEC EDGAR.
Where does Trabud get ARMISTICE CAPITAL, LLC's insider trading data?
Directly from SEC EDGAR Form 4 filings. Every transaction on this page is a real filing accepted by the SEC, updated as new filings arrive.
Related Content
Track ARMISTICE CAPITAL, LLC and every other insider
Screen all SEC Form 4 filings by insider, company, transaction value, and role — or ask Trabud's AI agent in plain English.
Open the screener